|
A Phase I/II Study of Arsenic Trioxide/Bortezomib/Ascorbic Acid Combination Therapy for the Treatment of Relapsed or Refractory Multiple Myeloma - Clinical Cancer Research, March 2007
Click here to view abstract
Efficacy and Safety of Melphalan, Arsenic Trioxide and Ascorbic Acid Combination Therapy in Patients with Relapsed or Refractory Multiple Myeloma: a Prospective, Multicentre, Phase II, Single-Arm Study - British Journal of Haematology, October 2006
Click here to view abstract
A Phase I/II Trial Assessing Bortezomib and Melphalan Combination Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma - Journal of Clinical Oncology, February 2006
Click here to view abstract
|
|
Posters Presented in 2007
Posters Presented in 2006
Posters Presented in 2005 |
|
| Visit our Exhibitor Booth at ASCO 2008 in Chicago. |
|
